Navigation Links
Mesa Labs Declares Quarterly Dividend
Date:8/9/2012

LAKEWOOD, Colo., Aug. 9, 2012 /PRNewswire/ -- Mesa Laboratories, Inc. (NASDAQ: MLAB) today announced that its Board of Directors has declared a regular quarterly cash dividend of 13 cents per share of common stock, payable on September 17, 2012 to shareholders of record at the close of business on August 29, 2012.

Mesa Laboratories develops, acquires, manufactures and markets, electronic instruments and disposables, for industrial, pharmaceutical and medical applications.

This news release contains forward-looking statements, which involve risks and uncertainties.  The Company's actual results could differ materially from those in any such forward-looking statements.  Additional information is contained in the Company's Annual Report on Form 10-K for the year ended March 31, 2012, as filed with the Securities and Exchange Commission, and from time to time in the Company's other reports on file with the Commission.


'/>"/>
SOURCE Mesa Laboratories, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Hawkins, Inc. Declares Semi-Annual Cash Dividend Of $0.34 Per Share
2. BD Board Declares Dividend
3. Young Innovations, Inc. Board of Directors Declares Quarterly Dividend
4. Lilly Declares Third-Quarter 2012 Dividend, Resumes Share Repurchase Program
5. Young Innovations, Inc. Board Of Directors Declares Quarterly Dividend
6. Zimmer Announces Quarterly Dividend for Second Quarter of 2012
7. Medical Marijuana Inc. (MJNA) Corporate Update on Industry Company Services and Future Development. First Audio-Webcast Interview With SmallCapVoice.com in Quarterly Series
8. Heska Announces Quarterly Dividend of $0.10 Per Share
9. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
10. Cardinal Health Board Of Directors Approves Cash Dividend; Authorizes New $750 Million Share Repurchase Program
11. Cantel Medical Board Of Directors Authorizes Regular Semiannual Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... CHICAGO , Oct. 11, 2017  Hill-Rom Holdings, ... its Aspen Surgical facility in Las Piedras, ... surgical scalpels and blades. ... confirmed that the facility sustained minor structural damage, temporary ... Hurricane Maria. Repairs have been completed, manufacturing operations have ...
(Date:10/5/2017)... Oct. 5, 2017  In response to the ... and Maxillofacial Surgeons (AAOMS) released prescribing recommendations that ... be used as a first-line therapy to manage ... Recognizing the value and ... Paper "Opioid Prescribing: Acute and Postoperative Pain Management" ...
(Date:10/2/2017)... 2, 2017 Diplomat Pharmacy, Inc. (NYSE: ... and Consulting, LLC , and named its founder as ... in Tennessee , will operate under ... EnvoyHealth,s service offerings for health care partners to include ... "In an interoperable world, technology delivers ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... one of the most popular and least understood books in the Holy Scriptures, Revelation. ... descriptions that have baffled scholars for centuries. Many have tossed it off as mere ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains ... possible to save lost souls in the Philippines. “The Journey: From the Mountains to ... dedicated teacher of the Bible. She has taught all ages and currently teaches a ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... ... ... IsoComforter, Inc. ( https://isocomforter.com ), one of the Nation’s premier ... of the shoulder pad. The shoulder pad provides optimal support and full contact ... using cold therapy. By utilizing ice and water that is circulated from an insulated ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
Breaking Medicine News(10 mins):